請用此 Handle URI 來引用此文件：
http://tdr.lib.ntu.edu.tw/jspui/handle/123456789/29174完整後設資料紀錄
| DC 欄位 | 值 | 語言 |
|---|---|---|
| dc.contributor.advisor | 許翠瑛 | |
| dc.contributor.author | Wan-Fen Li | en |
| dc.contributor.author | 李菀芬 | zh_TW |
| dc.date.accessioned | 2021-06-13T00:44:39Z | - |
| dc.date.available | 2012-08-08 | |
| dc.date.copyright | 2007-08-08 | |
| dc.date.issued | 2007 | |
| dc.date.submitted | 2007-07-24 | |
| dc.identifier.citation | Adams, A., and T. Lindahl. 1975. Epstein-Barr virus genomes with properties of circular DNA molecules in carrier cells. Proc Natl Acad Sci U S A 72:1477-81.
Adamson, A. L., D. Darr, E. Holley-Guthrie, R. A. Johnson, A. Mauser, J. Swenson, and S. Kenney. 2000. Epstein-Barr virus immediate-early proteins BZLF1 and BRLF1 activate the ATF2 transcription factor by increasing the levels of phosphorylated p38 and c-Jun N-terminal kinases. J Virol 74:1224-33. Adamson, A. L., and S. C. Kenney. 1998. Rescue of the Epstein-Barr virus BZLF1 mutant, Z(S186A), early gene activation defect by the BRLF1 gene product. Virology 251:187-97. Anantharam, V., M. Kitazawa, J. Wagner, S. Kaul, and A. G. Kanthasamy. 2002. Caspase-3-dependent proteolytic cleavage of protein kinase C delta is essential for oxidative stress-mediated dopaminergic cell death after exposure to methylcyclopentadienyl manganese tricarbonyl. J Neurosci 22:1738-51. Baer, R., A. T. Bankier, M. D. Biggin, P. L. Deininger, P. J. Farrell, T. J. Gibson, G. Hatfull, G. S. Hudson, S. C. Satchwell, C. Seguin, and et al. 1984. DNA sequence and expression of the B95-8 Epstein-Barr virus genome. Nature 310:207-11. Basu, A., and G. R. Akkaraju. 1999. Regulation of caspase activation and cis-diamminedichloroplatinum(II)-induced cell death by protein kinase C. Biochemistry 38:4245-51. Bharti, A., S. K. Kraeft, M. Gounder, P. Pandey, S. Jin, Z. M. Yuan, S. P. Lees-Miller, R. Weichselbaum, D. Weaver, L. B. Chen, D. Kufe, and S. Kharbanda. 1998. Inactivation of DNA-dependent protein kinase by protein kinase C delta: implications for apoptosis. Mol Cell Biol 18:6719-28. Bharti, A., S. K. Kraeft, M. Gounder, P. Pandey, S. Jin, Z. M. Yuan, S. P. Lees-Miller, R. Weichselbaum, D. Weaver, L. B. Chen, D. Kufe, and S. Kharbanda. 1998. Inactivation of DNA-dependent protein kinase by protein kinase C delta: implications for apoptosis. Mol Cell Biol 18:6719-28. Blachon, S., and C. Demeret. 2003. The regulatory E2 proteins of human genital papillomaviruses are pro-apoptotic. Biochimie 85:813-9. Blank, M., and Y. Shiloh. 2007. Programs for cell death: apoptosis is only one way to go. Cell Cycle 6:686-95. Blass, M., I. Kronfeld, G. Kazimirsky, P. M. Blumberg, and C. Brodie. 2002. Tyrosine phosphorylation of protein kinase C delta is essential for its apoptotic effect in response to etoposide. Mol Cell Biol 22:182-95. Burke, A. P., T. S. Yen, K. M. Shekitka, and L. H. Sobin. 1990. Lymphoepithelial carcinoma of the stomach with Epstein-Barr virus demonstrated by polymerase chain reaction. Mod Pathol 3:377-80. Burkitt, D. 1958. A sarcoma involving the jaws in African children. Br J Surg 46:218-23. Chang, P. J., Y. S. Chang, and S. T. Liu. 1998. Role of Rta in the translation of bicistronic BZLF1 of Epstein-Barr virus. J Virol 72:5128-36. Chang, P. J., and S. T. Liu. 2001. Function of the intercistronic region of BRLF1-BZLF1 bicistronic mRNA in translating the zta protein of Epstein-Barr virus. J Virol 75:1142-51. Chang, Y., C. H. Tung, Y. T. Huang, J. Lu, J. Y. Chen, and C. H. Tsai. 1999. Requirement for cell-to-cell contact in Epstein-Barr virus infection of nasopharyngeal carcinoma cells and keratinocytes. J Virol 73:8857-66. Chaudhari, B. R., R. F. Murphy, and D. K. Agrawal. 2006. Following the TRAIL to apoptosis. Immunol Res 35:249-62. Chen, N., W. Ma, C. Huang, and Z. Dong. 1999. Translocation of protein kinase C epsilon and protein kinase C delta to membrane is required for ultraviolet B-induced activation of mitogen-activated protein kinases and apoptosis. J Biol Chem 274:15389-94. Chevallier-Greco, A., E. Manet, P. Chavrier, C. Mosnier, J. Daillie, and A. Sergeant. 1986. Both Epstein-Barr virus (EBV)-encoded trans-acting factors, EB1 and EB2, are required to activate transcription from an EBV early promoter. EMBO J 5:3243-9. Cho, M. S., G. Milman, and S. D. Hayward. 1985. A second Epstein-Barr virus early antigen gene in BamHI fragment M encodes a 48- to 50-kilodalton nuclear protein. J Virol 56:860-6. Clough, W. 1979. Deoxyribonuclease activity found in Epstein--Barr virus producing lymphoblastoid cells. Biochemistry 18:4517-21. Countryman, J., H. Jenson, R. Seibl, H. Wolf, and G. Miller. 1987. Polymorphic proteins encoded within BZLF1 of defective and standard Epstein-Barr viruses disrupt latency. J Virol 61:3672-9. Countryman, J., and G. Miller. 1985. Activation of expression of latent Epstein-Barr herpesvirus after gene transfer with a small cloned subfragment of heterogeneous viral DNA. Proc Natl Acad Sci U S A 82:4085-9. Cox, M. A., J. Leahy, and J. M. Hardwick. 1990. An enhancer within the divergent promoter of Epstein-Barr virus responds synergistically to the R and Z transactivators. J Virol 64:313-21. Craig, R. W. 1995. The bcl-2 gene family. Semin Cancer Biol 6:35-43. Cross, T., G. Griffiths, E. Deacon, R. Sallis, M. Gough, D. Watters, and J. M. Lord. 2000. PKC-delta is an apoptotic lamin kinase. Oncogene 19:2331-7. Deacon, E. M., J. Pongracz, G. Griffiths, and J. M. Lord. 1997. Isoenzymes of protein kinase C: differential involvement in apoptosis and pathogenesis. Mol Pathol 50:124-31. Demeret, C., A. Garcia-Carranca, and F. Thierry. 2003. Transcription-independent triggering of the extrinsic pathway of apoptosis by human papillomavirus 18 E2 protein. Oncogene 22:168-75. Denning, M. F., A. A. Dlugosz, D. W. Threadgill, T. Magnuson, and S. H. Yuspa. 1996. Activation of the epidermal growth factor receptor signal transduction pathway stimulates tyrosine phosphorylation of protein kinase C delta. J Biol Chem 271:5325-31. Denning, M. F., Y. Wang, B. J. Nickoloff, and T. Wrone-Smith. 1998. Protein kinase C delta is activated by caspase-dependent proteolysis during ultraviolet radiation-induced apoptosis of human keratinocytes. J Biol Chem 273:29995-30002. Dolyniuk, M., R. Pritchett, and E. Kieff. 1976. Proteins of Epstein-Barr virus. I. Analysis of the polypeptides of purified enveloped Epstein-Barr virus. J Virol 17:935-49. El-Guindy, A. S., L. Heston, Y. Endo, M. S. Cho, and G. Miller. 2002. Disruption of Epstein-Barr virus latency in the absence of phosphorylation of ZEBRA by protein kinase C. J Virol 76:11199-208. Emoto, Y., Y. Manome, G. Meinhardt, H. Kisaki, S. Kharbanda, M. Robertson, T. Ghayur, W. W. Wong, R. Kamen, R. Weichselbaum, and et al. 1995. Proteolytic activation of protein kinase C delta by an ICE-like protease in apoptotic cells. EMBO J 14:6148-56. Epstein, M. A., B. G. Achong, and Y. M. Barr. 1964. Virus particles in cultured lymphoblasts from Burkitt's lymphoma. Lancet 15:702-3. Feederle, R., M. Kost, M. Baumann, A. Janz, E. Drouet, W. Hammerschmidt, and H. J. Delecluse. 2000. The Epstein-Barr virus lytic program is controlled by the co-operative functions of two transactivators. EMBO J 19:3080-9. Fujii, K., G. Zhu, Y. Liu, J. Hallam, L. Chen, J. Herrero, and S. Shaw. 2004. Kinase peptide specificity: improved determination and relevance to protein phosphorylation. Proc Natl Acad Sci U S A 101:13744-9. Fukumoto, S., Y. Nishizawa, M. Hosoi, H. Koyama, K. Yamakawa, S. Ohno, and H. Morii. 1997. Protein kinase C delta inhibits the proliferation of vascular smooth muscle cells by suppressing G1 cyclin expression. J Biol Chem 272:13816-22. Fukunaga, M., M. Oka, M. Ichihashi, T. Yamamoto, H. Matsuzaki, and U. Kikkawa. 2001. UV-induced tyrosine phosphorylation of PKC delta and promotion of apoptosis in the HaCaT cell line. Biochem Biophys Res Commun 289:573-9. Ghayur, T., M. Hugunin, R. V. Talanian, S. Ratnofsky, C. Quinlan, Y. Emoto, P. Pandey, R. Datta, Y. Huang, S. Kharbanda, H. Allen, R. Kamen, W. Wong, and D. Kufe. 1996. Proteolytic activation of protein kinase C delta by an ICE/CED 3-like protease induces characteristics of apoptosis. J Exp Med 184:2399-404. Given, D., and E. Kieff. 1979. DNA of Epstein-Barr virus. VI. Mapping of the internal tandem reiteration. J Virol 31:315-24. Given, D., D. Yee, K. Griem, and E. Kieff. 1979. DNA of Epstein-Barr virus. V. Direct repeats of the ends of Epstein-Barr virus DNA. J Virol 30:852-62. Gomez, D. E., G. Skilton, D. F. Alonso, and M. G. Kazanietz. 1999. The role of protein kinase C and novel phorbol ester receptors in tumor cell invasion and metastasis (Review). Oncol Rep 6:1363-70. Gruffat, H., N. Duran, M. Buisson, F. Wild, R. Buckland, and A. Sergeant. 1992. Characterization of an R-binding site mediating the R-induced activation of the Epstein-Barr virus BMLF1 promoter. J Virol 66:46-52. Gruffat, H., E. Manet, A. Rigolet, and A. Sergeant. 1990a. The enhancer factor R of Epstein-Barr virus (EBV) is a sequence-specific DNA binding protein. Nucleic Acids Res 18:6835-43. Gruffat, H., N. Moreno, and A. Sergeant. 1990b. The Epstein-Barr virus (EBV) ORI1yt enhancer is not B-cell specific and does not respond synergistically to the EBV transcription factors R and Z. J Virol 64:2810-8. Gruffat, H., and A. Sergeant. 1994. Characterization of the DNA-binding site repertoire for the Epstein-Barr virus transcription factor R. Nucleic Acids Res 22:1172-8. schwendt, M. 1999. Protein kinase C delta. Eur J Biochem 259:555-64. Hammerschmidt, W., and B. Sugden. 1988. Identification and characterization of oriLyt, a lytic origin of DNA replication of Epstein-Barr virus. Cell 55:427-33. Hampar, B., J. G. Derge, L. M. Martos, and J. L. Walker. 1971. Persistence of a repressed Epstein-Barr virus genome in Burkitt lymphoma cells made resistant to 5-bromodeoxyuridine. Proc Natl Acad Sci U S A 68:3185-9. Hardwick, J. M., P. M. Lieberman, and S. D. Hayward. 1988. A new Epstein-Barr virus transactivator, R, induces expression of a cytoplasmic early antigen. J Virol 62:2274-84. Hardwick, J. M., L. Tse, N. Applegren, J. Nicholas, and M. A. Veliuona. 1992. The Epstein-Barr virus R transactivator (Rta) contains a complex, potent activation domain with properties different from those of VP16. J Virol 66:5500-8. Hatfull, G., A. T. Bankier, B. G. Barrell, and P. J. Farrell. 1988. Sequence analysis of Raji Epstein-Barr virus DNA. Virology 164:334-40. Henle, G., and W. Henle. 1966. Studies on cell lines derived from Burkitt's lymphoma. Trans N Y Acad Sci 29:71-9. Henle, G., W. Henle, and V. Diehl. 1968. Relation of Burkitt's tumor-associated herpes-ytpe virus to infectious mononucleosis. Proc Natl Acad Sci U S A 59:94-101. Holley-Guthrie, E. A., E. B. Quinlivan, E. C. Mar, and S. Kenney. 1990. The Epstein-Barr virus (EBV) BMRF1 promoter for early antigen (EA-D) is regulated by the EBV transactivators, BRLF1 and BZLF1, in a cell-specific manner. J Virol 64:3753-9. Hoshikawa, Y., Y. Satoh, M. Murakami, M. Maeta, N. Kaibara, H. Ito, T. Kurata, and T. Sairenji. 2002. Evidence of lytic infection of Epstein-Barr virus (EBV) in EBV-positive gastric carcinoma. J Med Virol 66:351-9. Hsu, T. Y., Y. Chang, P. W. Wang, M. Y. Liu, M. R. Chen, J. Y. Chen, and C. H. Tsai. 2005. Reactivation of Epstein-Barr virus can be triggered by an Rta protein mutated at the nuclear localization signal. J Gen Virol 86:317-22. Huang, D. P., J. H. Ho, W. K. Chan, W. H. Lau, and M. Lui. 1989. Cytogenetics of undifferentiated nasopharyngeal carcinoma xenografts from southern Chinese. Int J Cancer 43:936-9. Huang, J., H. Chen, L. Hutt-Fletcher, R. F. Ambinder, and S. D. Hayward. 2003. Lytic viral replication as a contributor to the detection of Epstein-Barr virus in breast cancer. J Virol 77:13267-74. Hung, C. H., and S. T. Liu. 1999. Characterization of the Epstein-Barr virus BALF2 promoter. J Gen Virol 80:2747-50. Hunsperger, E. A., and C. L. Wilcox. 2003. Caspase-3-dependent reactivation of latent herpes simplex virus type 1 in sensory neuronal cultures. J Neurovirol 9:390-8. Inman, G. J., U. K. Binne, G. A. Parker, P. J. Farrell, and M. J. Allday. 2001. Activators of the Epstein-Barr virus lytic program concomitantly induce apoptosis, but lytic gene expression protects from cell death. J Virol 75:2400-10. Inoue, M., A. Kishimoto, Y. Takai, and Y. Nishizuka. 1977. Studies on a cyclic nucleotide-independent protein kinase and its proenzyme in mammalian tissues. II. Proenzyme and its activation by calcium-dependent protease from rat brain. J Biol Chem 252:7610-6. Jones, J. F., S. Shurin, C. Abramowsky, R. R. Tubbs, C. G. Sciotto, R. Wahl, J. Sands, D. Gottman, B. Z. Katz, and J. Sklar. 1988. T-cell lymphomas containing Epstein-Barr viral DNA in patients with chronic Epstein-Barr virus infections. N Engl J Med 318:733-41. Kallin, B., L. Sternas, A. K. Saemundssen, J. Luka, H. Jornvall, B. Eriksson, P. Z. Tao, M. T. Nilsson, and G. Klein. 1985. Purification of Epstein-Barr virus DNA polymerase from P3HR-1 cells. J Virol 54:561-8. Kenney, S., E. Holley-Guthrie, E. C. Mar, and M. Smith. 1989. The Epstein-Barr virus BMLF1 promoter contains an enhancer element that is responsive to the BZLF1 and BRLF1 transactivators. J Virol 63:3878-83. Kikkawa, U., H. Matsuzaki, and T. Yamamoto. 2002. Protein kinase C delta (PKC delta): activation mechanisms and functions. J Biochem (Tokyo) 132:831-9. Kikuta, H., Y. Taguchi, K. Tomizawa, K. Kojima, N. Kawamura, A. Ishizaka, Y. Sakiyama, S. Matsumoto, S. Imai, T. Kinoshita, and et al. 1988. Epstein-Barr virus genome-positive T lymphocytes in a boy with chronic active EBV infection associated with Kawasaki-like disease. Nature 333:455-7. Klein, G., P. Clifford, E. Klein, and J. Stjernsward. 1966. Search for tumor-specific immune reactions in Burkitt lymphoma patients by the membrane immunofluorescence reaction. Proc Natl Acad Sci U S A 55:1628-35. Konishi, H., M. Tanaka, Y. Takemura, H. Matsuzaki, Y. Ono, U. Kikkawa, and Y. Nishizuka. 1997. Activation of protein kinase C by tyrosine phosphorylation in response to H2O2. Proc Natl Acad Sci U S A 94:11233-7. Kudoh, A., T. Daikoku, Y. Sugaya, H. Isomura, M. Fujita, T. Kiyono, Y. Nishiyama, and T. Tsurumi. 2004. Inhibition of S-phase cyclin-dependent kinase activity blocks expression of Epstein-Barr virus immediate-early and early genes, preventing viral lytic replication. J Virol 78:104-15. Lee, Y. J., J. W. Soh, N. M. Dean, C. K. Cho, T. H. Kim, S. J. Lee, and Y. S. Lee. 2002. Protein kinase C delta overexpression enhances radiation sensitivity via extracellular regulated protein kinase 1/2 activation, abolishing the radiation-induced G(2)-M arrest. Cell Growth Differ 13:237-46. Leverrier, S., A. Vallentin, and D. Joubert. 2002. Positive feedback of protein kinase C proteolytic activation during apoptosis. Biochem J 368:905-13. Li, W., H. Mischak, J. C. Yu, L. M. Wang, J. F. Mushinski, M. A. Heidaran, and J. H. Pierce. 1994. Tyrosine phosphorylation of protein kinase C-delta in response to its activation. J Biol Chem 269:2349-52. Lin, C. T., W. Y. Chan, W. Chen, H. M. Huang, H. C. Wu, M. M. Hsu, S. M. Chuang, and C. C. Wang. 1993. Characterization of seven newly established nasopharyngeal carcinoma cell lines. Lab Invest 68:716-27. Littler, E., and J. R. Arrand. 1988. Characterization of the Epstein-Barr virus-encoded thymidine kinase expressed in heterologous eucaryotic and procaryotic systems. J Virol 62:3892-5. Liu, C., N. D. Sista, and J. S. Pagano. 1996. Activation of the Epstein-Barr virus DNA polymerase promoter by the BRLF1 immediate-early protein is mediated through USF and E2F. J Virol 70:2545-55. Majumder, P. K., N. C. Mishra, X. Sun, A. Bharti, S. Kharbanda, S. Saxena, and D. Kufe. 2001. Targeting of protein kinase C delta to mitochondria in the oxidative stress response. Cell Growth Differ 12:465-70. Majumder, P. K., P. Pandey, X. Sun, K. Cheng, R. Datta, S. Saxena, S. Kharbanda, and D. Kufe. 2000. Mitochondrial translocation of protein kinase C delta in phorbol ester-induced cytochrome c release and apoptosis. J Biol Chem 275:21793-6. Manet, E., C. Allera, H. Gruffat, I. Mikaelian, A. Rigolet, and A. Sergeant. 1993. The acidic activation domain of the Epstein-Barr virus transcription factor R interacts in vitro with both TBP and TFIIB and is cell-specifically potentiated by a proline-rich region. Gene Expr 3:49-59. Manet, E., H. Gruffat, M. C. Trescol-Biemont, N. Moreno, P. Chambard, J. F. Giot, and A. Sergeant. 1989. Epstein-Barr virus bicistronic mRNAs generated by facultative splicing code for two transcriptional trans-activators. Embo J 8:1819-2679. Manet, E.,A. Rigolet, H. Gruffat, J. F. Giot, and A. Sergeant. 1991. Domains of the Epstein-Barr virus (EBV) transcription factor R required for dimerization, DNA binding and activation. Nucleic Acids Res 19:2661-7. Marschall, M., U. Leser, R. Seibl, and H. Wolf. 1989. Identification of proteins encoded by Epstein-Barr virus trans-activator genes. J Virol 63:938-42. Martel-Renoir, D., V. Grunewald, R. Touitou, G. Schwaab, and I. Joab. 1995. Qualitative analysis of the expression of Epstein-Barr virus lytic genes in nasopharyngeal carcinoma biopsies. J Gen Virol 76:1401-8. Matassa, A. A., L. Carpenter, T. J. Biden, M. J. Humphries, and M. E. Reyland. 2001. PKC delta is required for mitochondrial-dependent apoptosis in salivary epithelial cells. J Biol Chem 276:29719-28. Miller, R. L., R. Glaser, and F. Rapp. 1977. Studies of an Epstein-Barr virus-induced DNA polymerase. Virology 76:494-502. Mizuno, K., K. Noda, T. Araki, T. Imaoka, Y. Kobayashi, Y. Akita, M. Shimonaka, S. Kishi, and S. Ohno. 1997. The proteolytic cleavage of protein kinase C isotypes, which generates kinase and regulatory fragments, correlates with Fas-mediated and 12-O-tetradecanoyl-phorbol-13-acetate-induced apoptosis. Eur J Biochem 250:7-18. Muranyi, W., J. Haas, M. Wagner, G. Krohne, and U. H. Koszinowski. 2002. Cytomegalovirus recruitment of cellular kinases to dissolve the nuclear lamina. Science 297:854-7. Newton, A. C. 2001. Protein kinase C: structural and spatial regulation by phosphorylation, cofactors, and macromolecular interactions. Chem Rev 101:2353-64. Old, L. J., E. A. Boyse, H. F. Oettgen, E. D. Harven, G. Geering, B. Williamson, and P. Clifford. 1966. Precipitating Antibody in Human Serum to an Antigen Present in Cultured Burkitt's Lymphoma Cells. Proc Natl Acad Sci U S A 56:1699-1704. Ono, Y., T. Fujii, K. Ogita, U. Kikkawa, K. Igarashi, and Y. Nishizuka. 1987. Identification of three additional members of rat protein kinase C family: delta-, epsilon- and zeta-subspecies. FEBS Lett 226:125-8. Park, R., and J. D. Baines. 2006. Herpes simplex virus type 1 infection induces activation and recruitment of protein kinase C to the nuclear membrane and increased phosphorylation of lamin B. J Virol 80:494-504. Quinlivan, E. B., E. A. Holley-Guthrie, M. Norris, D. Gutsch, S. L. Bachenheimer, and S. C. Kenney. 1993. Direct BRLF1 binding is required for cooperative BZLF1/BRLF1 activation of the Epstein-Barr virus early promoter, BMRF1. Nucleic Acids Res 21:1999-2007. Ragoczy, T., L. Heston, and G. Miller. 1998. The Epstein-Barr virus Rta protein activates lytic cycle genes and can disrupt latency in B lymphocytes. J Virol 72:7978-84. Ragoczy, T., and G. Miller. 1999. Role of the Epstein-Barr virus RTA protein in activation of distinct classes of viral lytic cycle genes. J Virol 73:9858-66. Ragoczy, T., and G. Miller. 2001. Autostimulation of the Epstein-Barr virus BRLF1 promoter is mediated through consensus Sp1 and Sp3 binding sites. J Virol 75:5240-51. Ren, J., R. Datta, H. Shioya, Y. Li, E. Oki, V. Biedermann, A. Bharti, and D. Kufe. 2002. P73 beta is regulated by protein kinase C delta catalytic fragment generated in the apoptotic response to DNA damage. J Biol Chem 277:33758-65. Reyland, M. E., S. M. Anderson, A. A. Matassa, K. A. Barzen, and D. O. Quissell. 1999. Protein kinase C delta is essential for etoposide-induced apoptosis in salivary gland acinar cells. J Biol Chem 274:19115-23. Robles-Flores, M., E. Rendon-Huerta, H. Gonzalez-Aguilar, G. Mendoza-Hernandez, S. Islas, V. Mendoza, M. V. Ponce-Castaneda, L. Gonzalez-Mariscal, and F. Lopez-Casillas. 2002. P32 (gC1qBP) is a general protein kinase C (PKC)-binding protein; interaction and cellular localization of P32-PKC complexes in rat hepatocytes. J Biol Chem 277:5247-55. Sanfilippo, C. M., F. N. Chirimuuta, and J. A. Blaho. 2004. Herpes simplex virus type 1 immediate-early gene expression is required for the induction of apoptosis in human epithelial HEp-2 cells. J Virol 78:224-39. Santiago-Walker, A. E., A. J. Fikaris, G. D. Kao, E. J. Brown, M. G. Kazanietz, and J. L. Meinkoth. 2005. Protein kinase C delta stimulates apoptosis by initiating G1 phase cell cycle progression and S phase arrest. J Biol Chem 280:32107-14. Scheel-Toellner, D., D. Pilling, A. N. Akbar, D. Hardie, G. Lombardi, M. Salmon, and J. M. Lord. 1999. Inhibition of T cell apoptosis by IFN-beta rapidly reverses nuclear translocation of protein kinase C-delta. Eur J Immunol 29:2603-12. Shen, H. M., and S. Pervaiz. 2006. TNF receptor superfamily-induced cell death: redox-dependent execution. FASEB J 20:1589-98. Shi, Y. 2002. Apoptosome: the cellular engine for the activation of caspase-9. Structure 10:285-8. Sixbey, J. W., E. H. Vesterinen, J. G. Nedrud, N. Raab-Traub, L. A. Walton, and J. S. Pagano. 1983. Replication of Epstein-Barr virus in human epithelial cells infected in vitro. Nature 306:480-3. Swenson, J. J., A. E. Mauser, W. K. Kaufmann, and S. C. Kenney. 1999. The Epstein-Barr virus protein BRLF1 activates S phase entry through E2F1 induction. J Virol 73:6540-50. Takada, K., and Y. Ono. 1989. Synchronous and sequential activation of latently infected Epstein-Barr virus genomes. J Virol 63:445-9. Takada, K., N. Shimizu, S. Sakuma, and Y. Ono. 1986. trans activation of the latent Epstein-Barr virus (EBV) genome after transfection of the EBV DNA fragment. J Virol 57:1016-22. Tovey, M. G., G. Lenoir, and J. Begon-Lours. 1978. Activation of latent Epstein-Barr virus by antibody to human IgM. Nature 276:270-2. Tsai, C. H., M. T. Liu, M. R. Chen, J. Lu, H. L. Yang, J. Y. Chen, and C. S. Yang. 1997. Characterization of monoclonal antibodies to the Zta and DNase proteins of Epstein-Barr virus. J Biomed Sci 4:69-77. Tsai, C. H., M. V. Williams, and R. Glaser. 1991. Characterization of two monoclonal antibodies to Epstein-Barr virus diffuse early antigen which react to two different epitopes and have different biological function. J Virol Methods 33:47-52. Tsai, W. S., M. H. Chang, J. Y. Chen, C. Y. Lee, and Y. G. Liu. 1989. Seroepidemiological study of Epstein-Barr virus infection in children in Taipei. Zhonghua Min Guo Xiao Er Ke Yi Xue Hui Za Zhi 30:81-6.111. Walling, D. M., S. N. Edmiston, J. W. Sixbey, M. Abdel-Hamid, L. Resnick, and N. Raab-Traub. 1992. Coinfection with multiple strains of the Epstein-Barr virus in human immunodeficiency virus-associated hairy leukoplakia. Proc Natl Acad Sci U S A 89:6560-4. Weiss, L. M., J. G. Strickler, R. A. Warnke, D. T. Purtilo, and J. Sklar. 1987. Epstein-Barr viral DNA in tissues of Hodgkin's disease. Am J Pathol 129:86-91. Williams, G. T. 1991. Programmed cell death: apoptosis and oncogenesis. Cell 65:1097-8. Yates, J., N. Warren, D. Reisman, and B. Sugden. 1984. A cis-acting element from the Epstein-Barr viral genome that permits stable replication of recombinant plasmids in latently infected cells. Proc Natl Acad Sci U S A 81:3806-10. Yates, J. L., N. Warren, and B. Sugden. 1985. Stable replication of plasmids derived from Epstein-Barr virus in various mammalian cells. Nature 313:812-5. Yoshizaki, T., H. Miwa, H. Takeshita, H. Sato, and M. Furukawa. 2000. Elevation of antibody against Epstein-Barr virus genes BRLF1 and BZLF1 in nasopharyngeal carcinoma. J Cancer Res Clin Oncol 126:69-73. Young, L. S., C. W. Dawson, D. Clark, H. Rupani, P. Busson, T. Tursz, A. Johnson, and A. B. Rickinson. 1988. Epstein-Barr virus gene expression in nasopharyngeal carcinoma. J Gen Virol 69:1051-65117. Yuan, Z. M., T. Utsugisawa, T. Ishiko, S. Nakada, Y. Huang, S. Kharbanda, R. Weichselbaum, and D. Kufe. 1998. Activation of protein kinase C delta by the c-Abl tyrosine kinase in response to ionizing radiation. Oncogene 16:1643-8. Zalani, S., E. Holley-Guthrie, and S. Kenney. 1996. Epstein-Barr viral latency is disrupted by the immediate-early BRLF1 protein through a cell-specific mechanism. Proc Natl Acad Sci U S A 93:9194-9. zur Hausen, H., F. J. O'Neill, U. K. Freese, and E. Hecker. 1978. Persisting oncogenic herpesvirus induced by the tumour promotor TPA. Nature 272:373-5. | |
| dc.identifier.uri | http://tdr.lib.ntu.edu.tw/jspui/handle/123456789/29174 | - |
| dc.description.abstract | Epstein – Barr virus (EBV) R transactivator (Rta)是EBV進入裂解期時所表現的特早期蛋白 (immediate-early protein)。1999年，Swenson等人發現在Rta表現的人類纖維母細胞 (normal human fibroblast, NHF)及人類子宮頸癌上皮細胞株 (HeLa)中觀察到細胞凋亡現象的發生。此現象在本實驗室亦可觀察到，Rta蛋白之表現可促進死亡細胞增加。因此本研究希望探討EB病毒特早期活化子 Rta是否會導致細胞凋亡，並進一步了解其發生機轉及對於EB病毒複製與致病過程的重要性。
首先，我們在HeLa或HEp2細胞株中，證實Rta的確可以造成細胞凋亡。其次，在有Rta表現的情況下，則發現Rta可以使PKC-δ的cleavage form 上升，促使PKC-δ活化，進而導致細胞凋亡。接下來，利用Rottlerin或是 PKC-δ dominant negative突變蛋白可防止Rta所造成的細胞凋亡現象，證實Rta需要透過PKC-δ促成細胞凋亡。另外，我們也發現，不論是在pRTS15的細胞轉染實驗中，或是在EB病毒進入裂解期的NA細胞株中，皆可觀察到PKC- δ從細胞質進入細胞核中的量有增加的趨勢。進一步在免疫螢光染色的觀察及雙向免疫沉澱的實驗中，我們證明了Rta會和PKC-δ結合。除此之外，我們也發現抑制細胞凋亡並不會抑制EB病毒裂解期 (lytic cycle)的發生，而抑制PKC-δ的活性卻會抑制裂解期的進行。我們推論：PKC-δ也許是Rta促進EB病毒進入裂解期及導致細胞凋亡訊息傳遞發生的上游蛋白質。 | zh_TW |
| dc.description.abstract | Transactivator, Rta, encoded by the Epstein-Barr virus (EBV) immediate -early gene, BRLF1, mediates the switch from latency into lytic cycle. In 1999, Swenson et al observed that Rta expression can induce cell apoptosis in normal human fibroblast (NHF) and human cervical carcinoma cell line (HeLa). This phenomenon also can be observed in our laboratory. According to these findings, we intended to investigate whether Rta contributes to cell apoptosis in the human epithelial cells, and whether apoptosis is important to EBV lytic cycle progression.
At first, EBV Rta induced cell apoptosis could be demonstrated in HeLa and HEp2 cell lines. Secondly, Rta increased cleavage form of PKC-δ could be detected in the presence of Rta. Using rottlerin or PKC-δ dominant negative mutant to inhibit cellular PKC-δ activity, the phenomena that Rta induced cell apoptosis was reduced. Additionally, PKC-δ translocated from cytosol to nucleus was observed both in pRTS15 transiently transfected HeLa cells or trichostatin A (TSA) induced NA cells. Co-immunoprecipitation assay and immunofluorescent staining demonstrated the interaction between Rta and PKC-δ. Furthermore, the EBV lytic cycle progession was suppressed by using PKC-.δ inhibitor, rottlerin. However, EBV lytic cycle was not affected by treating cell with caspase inhibitor, Z-VAD-Fmk. Taken together, these studies suggest that PKC-δ is the upstream protein of Rta-mediated apoptotic signaling pathway and EBV lytic cycle progression induced by Rta. | en |
| dc.description.provenance | Made available in DSpace on 2021-06-13T00:44:39Z (GMT). No. of bitstreams: 1 ntu-96-R94445127-1.pdf: 2656791 bytes, checksum: 1104d24186148f9d31c1d76e5b65e356 (MD5) Previous issue date: 2007 | en |
| dc.description.tableofcontents | 謝辭…………………………………………………………………….I
中文摘要……………………………………………………………….II 英文摘要………………………………………………………………III 序論…………………………………………………………………….1 實驗目的………………………………………………………………17 實驗材料………………………………………………………………18 實驗方法………………………………………………………………25 實驗結果………………………………………………………………33 討論……………………………………………………………………47 附圖……………………………………………………………………53 參考文獻………………………………………………………………76 | |
| dc.language.iso | zh-TW | |
| dc.subject | PKC-δ | zh_TW |
| dc.subject | 細胞凋亡 | zh_TW |
| dc.subject | Rta | zh_TW |
| dc.subject | EBV | zh_TW |
| dc.subject | apoptosis | en |
| dc.subject | Rta | en |
| dc.subject | EBV | en |
| dc.subject | PKC-δ | en |
| dc.title | EB 病毒轉活化子Rta 會透過蛋白質激酶C-delta 促進細胞凋亡 | zh_TW |
| dc.title | Epstein-Barr virus immediate-early protein, Rta,
induces cell apoptosis through protein kinase C-δ | en |
| dc.type | Thesis | |
| dc.date.schoolyear | 95-2 | |
| dc.description.degree | 碩士 | |
| dc.contributor.oralexamcommittee | 林素芳,陳振揚 | |
| dc.subject.keyword | EBV,Rta,細胞凋亡,PKC-δ, | zh_TW |
| dc.subject.keyword | EBV,Rta,apoptosis,PKC-δ, | en |
| dc.relation.page | 87 | |
| dc.rights.note | 有償授權 | |
| dc.date.accepted | 2007-07-25 | |
| dc.contributor.author-college | 醫學院 | zh_TW |
| dc.contributor.author-dept | 微生物學研究所 | zh_TW |
| 顯示於系所單位： | 微生物學科所 | |
文件中的檔案：
| 檔案 | 大小 | 格式 | |
|---|---|---|---|
| ntu-96-1.pdf 未授權公開取用 | 2.59 MB | Adobe PDF |
系統中的文件，除了特別指名其著作權條款之外，均受到著作權保護，並且保留所有的權利。